1,600 results on '"Masumori, Naoya"'
Search Results
152. Construction of Predictive Models for Cancer-specific Survival of Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Results from a Multicenter Retrospective Study
153. Impact of visceral fat ratio on sleep-related erection: A retrospective study of elderly patients
154. Metachronous testicular seminoma occurring 8 years after treatment of extragonadal nonseminomatous germ cell tumor in the retroperitoneum
155. Natural History of Lower Urinary Tract Symptoms Secondary to BPH
156. Transurethral prostate biopsy before radical cystectomy remains clinically relevant for decision-making on urethrectomy in patients with bladder cancer
157. Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma
158. Dilemma of physician-mothers faced with an increased home burden and clinical duties in the hospital during the COVID-19 pandemic
159. Sequential Therapy with Docetaxel and Cabazitaxel Starting at Low PSA Levels was Associated with Longer Survival in Patients with Castration-Resistant Prostate Cancer
160. Cardiovascular safety of vibegron, a new β3‐adrenoceptor agonist, in older patients with overactive bladder: Post‐hoc analysis of a randomized, placebo‐controlled, double‐blind comparative phase 3 study
161. Reduction of susceptibility to azoles and 5-fluorocytosine and growth acceleration in Candida albicans by glucose in urine
162. Neuregulin-1-β1 and γ-secretase play a critical role in sphere-formation and cell survival of urothelial carcinoma cancer stem-like cells
163. Bilateral ureteral reconstruction using appendicular interposition combined with Wallace anastomosis following stenosis after radical cystectomy and ileal neobladder construction
164. Lymph node metastasis mapping in extended lymphadenectomy to the level of the inferior mesenteric artery for bladder cancer
165. Inhibition of Seminal Emission Is the Main Cause of Anejaculation Induced by a New Highly Selective α1A-Blocker in Normal Volunteers
166. Role of lymph node dissection in management of bladder cancer
167. Autoantibody against hypoxia-inducible factor prolyl hydroxylase-3 is a potential serological marker for renal cell carcinoma
168. Magnetic Resonance Imaging Is Accurate to Detect Bleeding in the Seminal Vesicles in Patients With Hemospermia
169. Acute Normovolemic Hemodilution for Radical Retropubic Prostatectomy and Radical Cystectomy
170. Complete response to interferon-alpha in a patient with metastatic renal cell carcinoma after unsuccessful molecular-targeted therapies
171. Risk factors for the development of well leg compartment syndrome after sex reassignment surgery in patients with gender identity disorder
172. Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer
173. Does Baseline Prostate Volume Affect the Short-Term Outcome of Tamsulosin?
174. LONG-TERM EFFICACY AND SAFETY OF ALPHA 1-BLOCKER NAFTOPIDIL FOR PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA: 3-YEAR OUTCOME ANALYSIS OF A PROSPECTIVE MULTICENTER STUDY.: PD23-12
175. INCIDENCE AND RISK FACTORS FOR ACUTE KIDNEY INJURY AFTER RADICAL CYSTECTOMY: MP60-01
176. N- AND O-GLYCOME ANALYSIS OF SERUM AND URINE FROM BLADDER CANCER PATIENTS USING A HIGH–THROUGHPUT GLYCOBLOTTING METHOD: MP39-04
177. Efficacy and safety of intravesical instillation of KRP‐116D (50% dimethyl sulfoxide solution) for interstitial cystitis/bladder pain syndrome in Japanese patients: A multicenter, randomized, double‐blind, placebo‐controlled, clinical study
178. What is the most anticipated change induced by treatment using gender‐affirming hormones in individuals with gender incongruence?
179. Does cognitive behavioral therapy using a self‐check sheet improve night‐time frequency in patients with nocturia? Results of a multicenter randomized controlled trial
180. Clinicopathological Analysis of Patients with Non-muscle-invasive Bladder Cancer: Prognostic Value and Clinical Reliability of the 2004 WHO Classification System
181. Additional file 1 of The neutrophil-lymphocyte ratio has a role in predicting the effectiveness of nivolumab in Japanese patients with metastatic renal cell carcinoma: a multi-institutional retrospective study
182. Additional file 2 of The neutrophil-lymphocyte ratio has a role in predicting the effectiveness of nivolumab in Japanese patients with metastatic renal cell carcinoma: a multi-institutional retrospective study
183. Successful Treatment by Surgery and Lenvatinib of a Patient with Adrenal Metastasis of Papillary Thyroid Cancer
184. Glomerulation Observed During Transurethral Resection of the Prostate for Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia is a Common Finding But No Predictor of Clinical Outcome
185. Clinical Evaluation of Diagnostic and Treatment Protocol of Idiopathic Retroperitoneal Fibrosis Incorporating Consideration of Possible IgG4-Related Disease
186. A Case of Retroperitoneal Atypical Spindle Cell Lipomatous Tumor
187. Successful mycophenolate mofetil treatment of a patient with severe steroid‐refractory hepatitis evoked by nivolumab plus ipilimumab treatment for relapsed bladder cancer
188. Evaluation of Proteinuria Using Urine Protein : Creatine Ratio in Treatment with Molecular Targeted Agents for Advanced Renal Cell Carcinoma
189. Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable
190. CLINICOPATHOLOGICAL ANALYSIS OF PATIENTS WITH NONMUSCLE-INVASIVE BLADDER CANCER: PROGNOSTIC VALUE AND CLINICAL RELIABILITY OF THE WHO GRADING SYSTEM OF 2004: 1703
191. THE COMBINATION THERAPY OF IMIDAFENACIN AND TAMSULOSIN IS EFFECTIVE AND SAFE IN BENIGN PROSTATIC HYPERPLASIA PATIENTS WITH OVERACTIVE BLADDER; THE ONE YEAR RESULTS FROM ADDITION STUDY: 1389
192. α1-blocker tamsulosin as initial treatment for patients with benign prostatic hyperplasia: 5-year outcome analysis of a prospective multicenter study
193. Prostate cancer stem-like cells/cancer-initiating cells have an autocrine system of hepatocyte growth factor
194. Zoledronic acid but not somatostatin analogs exerts anti-tumor effects in a model of murine prostatic neuroendocrine carcinoma of the development of castration-resistant prostate cancer
195. Incidence and risk of treatment for benign prostatic hyperplasia in Japanese men: A 15-year longitudinal community-based study
196. A Role for Preoperative Systemic Chemotherapy in Node-positive Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy
197. Natural history of lower urinary tract symptoms in Japanese men from a 15-year longitudinal community-based study
198. Efficacy of vibegron in patients with overactive bladder: Multicenter prospective study of real‐world clinical practice in Japan, SCCOP study 19‐01.
199. Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings, in patients with bladder cancer—analysis of role of pelvic lymph node dissection
200. A case with fistula formation between a perinephric retroperitoneal abscess and the duodenum: successful outcome after conservative management
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.